What is Skye Bioscience, Inc. Common Stock (SKYE) stock price today?

Skye Bioscience, Inc. Common Stock (SKYE) currently trades at $0.88 per share. The stock has a market capitalization of $22.94M and a P/E ratio of —x.

Is SKYE stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Skye Bioscience, Inc. Common Stock has a Smart Value Score of 29/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 3/9 and Altman Z-Score is —.

Is Skye Bioscience, Inc. Common Stock financially healthy?

Skye Bioscience, Inc. Common Stock's Piotroski F-Score is 3/9 (weak financial health). The Altman Z-Score of — places it in the —.

SKYE

Skye Bioscience, Inc. Common Stock

NASDAQ: SKYE · HEALTHCARE · BIOTECHNOLOGY

$0.88

-1.71% today

Updated 2026-04-30

Market cap

$22.94M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.30

Dividend yield

—

52W range

$1 – $6

Volume

0.6M

Market cap

$22.94M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.30

Dividend yield

—

52W range

$1 – $6

Volume

0.6M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

7.3

Quality

B+

3.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$8.25

+838.78%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

2 Strong Buy4 Buy2 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Debt/equity 0.01x — low leverage

Risks

- Piotroski 3/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-9.77M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	—	—
Net income	$-19.48M	$-37.64M	$-26.57M	$-55.92M	$-14.44M
EPS	—	—	—	—	$-1.30
Free cash flow	$-12.77M	$-13.96M	$-26.84M	$-43.07M	$-9.77M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
SKYE	$22.94M	29	4.3	3.0	5.0	7.3	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Skye Bioscience, Inc. Common Stock trades at $0.88. Our Smart Value Score of 29/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score.

Frequently asked questions

What is Skye Bioscience, Inc. Common Stock's stock price?

Skye Bioscience, Inc. Common Stock (SKYE) trades at $0.88.

Is Skye Bioscience, Inc. Common Stock overvalued?

Smart Value Score 29/100 (Grade F, Strong Sell).

What is the price target of Skye Bioscience, Inc. Common Stock (SKYE)?

The analyst target price is $8.25, representing +838.8% upside from the current price of $0.88.

Piotroski F-Score?

3/9 — weak financial health.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

skyebioscience.com

Quick metrics

P/S ratio—

ROE-1.27%

Beta2.86

50D MA$0.86

200D MA$2.19

Shares out0.03B

Float0.02B

Short ratio—

Avg volume0.6M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

SKYE vs LLY →SKYE vs JNJ →SKYE vs ABBV →Stock screener →